← Open Payments lookup

MENG WU: Open Payments

NPI 1144861907 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,624 in 61 payments from 28 companies in 2025. Trend: 2023 $1,516 · 2024 $380 · 2025 $1,624

Food & beverage: $1,624
CompanyPaymentsAmount
Janssen Biotech, Inc.7$251
Merck Sharp & Dohme LLC7$168
ABBVIE INC.5$111
Pharmacosmos Therapeutics Inc.1$108
SOBI, INC4$107
TerSera Therapeutics LLC3$72
PharmaEssentia USA Corporation3$58
TAIHO ONCOLOGY, INC.2$57
Novartis Pharmaceuticals Corporation2$55
GlaxoSmithKline, LLC.2$54

Products named: RYBREVANT, KEYTRUDA, MONOFERRIC, Vonjo, EPKINLY, BESREMI, LONSURF, KISQALI.

Industry payments across TX — which companies pay providers there.